Z-0247-2022 Class III Terminated

Recalled by Ortho-Clinical Diagnostics, Inc. — Rochester, NY

FDA device recall Z-0247-2022 was initiated by Ortho-Clinical Diagnostics, Inc. on Oct 15, 2021 and is designated Class III. Reason for recall: Ortho Clinical Diagnostics confirmed a complaint that some VITROS Immunodiagnostic Products Anti-HBc IgM Controls Lot 1690 Controls Values booklet contained information for the incorrect product… The recall status is terminated (terminated Dec 18, 2023). Affected quantity: 191 units.

Recall details

Product Type
Devices
Report Date
Nov 24, 2021
Initiation Date
Oct 15, 2021
Termination Date
Dec 18, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
191 units

Product description

VITROS Immunodiagnostic Products Anti-HBc IgM Controls, Product Code 6801427 For use in monitoring the performance of the VITROS ECi/ECiQ/3600 Immunodiagnostic Systems and the VITROS 5600/XT 7600 Integrated Systems

Reason for recall

Ortho Clinical Diagnostics confirmed a complaint that some VITROS Immunodiagnostic Products Anti-HBc IgM Controls Lot 1690 Controls Values booklet contained information for the incorrect product. While the accuracy of patient test results is not affected by this issue, there is a potential for delayed results due to the troubleshooting of Quality Control results.

Distribution pattern

US (Domestic) distribution to states of: AZ, CA, CO, CT, FL, GA, LA, MA, MO, NJ, NY, OK, SC, SD, TX, UT, WA, WI, and WV. OUS (Foreign) distribution to Colombia.

Code information

Lot 1690 UDI 10758750001200

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-0247-2022
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-0247-2022. Report a data issue: hello@regdatalab.com.